Daniil Gataulin
Stock Analyst at Chardan Capital
(2.77)
# 1,918
Out of 4,740 analysts
58
Total ratings
30.77%
Success rate
2.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UBX Unity Biotechnology | Initiates: Buy | $6 | $2.27 | +164.32% | 1 | Jan 10, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $28 | $22.36 | +25.22% | 4 | Jan 7, 2025 | |
| CGTX Cognition Therapeutics | Maintains: Buy | $11 | $0.77 | +1,328.57% | 4 | Dec 19, 2024 | |
| CRVO CervoMed | Downgrades: Neutral | n/a | $2.15 | - | 3 | Dec 11, 2024 | |
| FBRX Forte Biosciences | Maintains: Buy | $64 | $15.47 | +313.70% | 3 | Dec 4, 2024 | |
| OTLK Outlook Therapeutics | Downgrades: Neutral | n/a | $2.05 | - | 7 | Dec 2, 2024 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $7.63 | +581.97% | 8 | Nov 20, 2024 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $36 | $5.95 | +505.04% | 2 | Nov 18, 2024 | |
| OCGN Ocugen | Maintains: Buy | $6 | $0.75 | +696.81% | 7 | Nov 18, 2024 | |
| CLSD Clearside Biomedical | Maintains: Buy | $6 | $0.94 | +537.96% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $33 | $8.55 | +285.96% | 8 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $40 | $4.44 | +801.21% | 5 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $3.43 | +6,313.81% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.01 | - | 2 | Jul 25, 2023 |
Unity Biotechnology
Jan 10, 2025
Initiates: Buy
Price Target: $6
Current: $2.27
Upside: +164.32%
Oculis Holding AG
Jan 7, 2025
Maintains: Buy
Price Target: $28
Current: $22.36
Upside: +25.22%
Cognition Therapeutics
Dec 19, 2024
Maintains: Buy
Price Target: $11
Current: $0.77
Upside: +1,328.57%
CervoMed
Dec 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.15
Upside: -
Forte Biosciences
Dec 4, 2024
Maintains: Buy
Price Target: $64
Current: $15.47
Upside: +313.70%
Outlook Therapeutics
Dec 2, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.05
Upside: -
REGENXBIO
Nov 20, 2024
Maintains: Buy
Price Target: $52
Current: $7.63
Upside: +581.97%
MeiraGTx Holdings
Nov 18, 2024
Maintains: Buy
Price Target: $36
Current: $5.95
Upside: +505.04%
Ocugen
Nov 18, 2024
Maintains: Buy
Price Target: $6
Current: $0.75
Upside: +696.81%
Clearside Biomedical
Nov 15, 2024
Maintains: Buy
Price Target: $6
Current: $0.94
Upside: +537.96%
Nov 8, 2024
Maintains: Buy
Price Target: $28 → $33
Current: $8.55
Upside: +285.96%
Jul 18, 2024
Maintains: Buy
Price Target: $4 → $40
Current: $4.44
Upside: +801.21%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $3.43
Upside: +6,313.81%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $8.01
Upside: -